CIC
ACET icon

Cornercap Investment Counsel’s Adicet Bio ACET Stock Holding History

Cornercap Investment Counsel’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,130
Closed -$26K – 464
2024
Q3 		$26K Sell
1,130
-1,287
-53% -$28.8K 0.01% 513
2024
Q2 		$46.8K Buy
2,417
+29
+1% +$777 0.01% 583
2024
Q1 		$89.8K Hold
2,388
– – 0.01% 585
2023
Q4 		$72.2K Hold
2,388
– – 0.01% 560
2023
Q3 		$52.3K Sell
2,388
-30
-1% -$1.06K 0.01% 545
2023
Q2 		$94K Buy
+2,418
New +$213K 0.02% 543

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Cornercap Investment Counsel's ACET Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of Adicet Bio (ACET) in Q4 2024, closing a stake of 1,130 shares — an estimated $26K sold.

Cornercap Investment Counsel first reported a position in ACET in Q2 2023 and held it in 6 quarters. The position peaked at $94K in Q2 2023. 64 funds tracked by Wall St. Rank hold ACET as of Q4 2024.

  • Cornercap Investment Counsel reported no remaining Adicet Bio position as of Q4 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 1,130 Adicet Bio shares in Q4 2024, an estimated $26K.
  • Cornercap Investment Counsel first reported a position in Adicet Bio in Q2 2023 and held it in 6 quarters.
  • Cornercap Investment Counsel's Adicet Bio position peaked at $94K in Q2 2023.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.